- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Four patient-facing articles funded by a GSK grant disclosed the funding only at the bottom of each page. PMCPA ruled a narrow…
Anonymous complaint about two restaurant-based promotional speaker meetings alleged public could overhear and hospitality was excessive. Panel found complainant did not prove…
An ex-employee alleged a Nebido BMJ ad implied men would become attractive to younger women (unlicensed). The Panel found the imagery reflected…
A GP challenged a Lipitor journal ad using a fireman analogy. The Panel and Appeal Board found it misleading for exaggerating urgency…
A primary care trust chief pharmacist complained that a representative and materials implied the REACH registry supported Plavix use. The Panel ruled…
Two BMJ advertisements for Gaviscon Advance used in-vitro data but implied in-vivo/clinical oesophageal protection and wider clinical benefit. The Panel ruled both…
A Diabetologia journal ad for Actos claimed “no long-term cardiovascular concerns” without adequately reflecting SPC qualifications and heart failure warnings. The Panel…
A Champix journal ad claimed significantly greater quit success vs NiQuitin CQ Clear at 12 weeks. The Panel ruled the claim misleading…
A GP practice complained about an Otsuka representative’s unprofessional email (sent from work email) containing disparaging comments about GPs. Breaches were found…
A NeoClarityn journal ad implied clinically supported ‘anti-inflammatory’ action. PMCPA found it inconsistent with the SPC and misleading, breaching Clauses 3.2 and…
A nurse complained a Ferinject brochure implied CosmoFer required a 6-hour infusion, causing anxiety about correct administration. Panel relied on an earlier…
GSK’s ESC 2009 symposium invite was held not to be disguised promotion, but because it referenced ambrisentan it was promotional and needed…
Consultants alleged Lilly’s Strattera Support Service meant company staff contacted patients and could give biased advice. Panel found contact was via independent…
Lilly was found in breach after a branded promotional presentation appeared to be part of a university diabetes course, and for an…
P&G’s Asacol materials used “confidence in colitis” without clear qualification, implying use across all colitis types (breach 3.2). A leavepiece also used…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.